Clinical Trial

Levels of Visfatin/NAMPT in Human Milk

Study acronym: VISFAMILK
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 14, 2024 (before its estimated April 23, 2025 completion). Its status may not reflect the trial's current state.
Summary
Visfatin, released in maternal milk at different concentrations related to the maternal conditions, could act as a biomarker with a prognostic/predictive value to determine different newborn clinical conditions, particularly the weight loss of the neonate.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-27.
Status change: Not Yet Recruiting → Recruiting 2024-11-12
Trial Details
NCT Number NCT06487286
Lead Sponsor Paolo Manzoni Study Group
Collaborators: Università degli Studi del Piemonte Orientale Amedeo Avogadro
Conditions Visfatin Levels in Maternal Milk Samples, Birth Weight
Enrollment 30 participants
Start Date 2024-10-24
Primary Completion 2025-04-23 (estimated)
Study Completion 2025-04-23 (estimated)
Updated on ClinicalTrials.gov 2024-11-14